Shares of Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) were up 1% during mid-day trading on Wednesday . The stock traded as high as $3.04 and last traded at $2.91, with a volume of 650,830 shares. The stock had previously closed at $2.88.

Separately, Maxim Group reaffirmed a “buy” rating on shares of Adamis Pharmaceuticals Corp. in a report on Tuesday, May 10th.

The firm’s 50 day moving average price is $2.84 and its 200 day moving average price is $5.20. The company’s market capitalization is $58.69 million.

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M).